Author

Máté Tamás Déri

Observed names: Déri, Máté Tamás, Máté Déri, Máté T. Déri

Observed institutions: Semmelweis University, Eötvös Loránd University, University of Ljubljana, Western New England University, Motorpharma (Hungary), Printnet (Hungary), Institute of Molecular Life Sciences, HUN-REN Centre for Agricultural Research, Plant Protection Institute, MyoKardia (United States), Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences

ORCID: 0000-0002-8261-5230

Observed ORCID: 0000-0002-8261-5230

OpenAlex ID: A5087736632

Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics

2017 · Katalin Tóth, Gábor Csukly, et al. · The International Journal of Neuropsychopharmacology · 51

Relevance of CYP2C9 Function in Valproate Therapy

2018 · Katalin Monostory, Andrea Nagy, et al. · Current Neuropharmacology · 49

Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status andNAT2Genotype

2016 · Katalin Tóth, Gábor Csukly, et al. · The International Journal of Neuropsychopharmacology · 37

Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia

2020 · Ádám Menus, Ádám Kiss, et al. · Scientific Reports · 31

Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction

2017 · Ádám Ferenc Kiss, Dorottya Vaskó, et al. · Pharmacological Reports · 30

Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects

2021 · Ferenc Fekete, Katalin Mangó, et al. · Scientific Reports · 29

Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure

2019 · Ádám Kiss, Ádám Menus, et al. · European Archives of Psychiatry and Clinical Neuroscience · 27

End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s

2020 · Máté Tamás Déri, Ádám Ferenc Kiss, et al. · Pharmacological Reports · 26

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients

2021 · Máté Déri, Zsófia Szakál-Tóth, et al. · Scientific Reports · 22

Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients

2020 · Nóra Csikány, Ádám Kiss, et al. · British Journal of Clinical Pharmacology · 16

Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2

2021 · Máté Gyimesi, Anna Á. Rauscher, et al. · Journal of Pharmacology and Experimental Therapeutics · 13

Isoform-Dependent Changes in Cytochrome P450-Mediated Drug Metabolism after Portal Vein Ligation in the Rat

2018 · Tibor Kovács, Máté Déri, et al. · European Surgical Research · 3

Works count: 13

Citation count: 334

H-index: 11

I10-index: 11